)
Visual
test
Bioventus
Bioventus (BVS) investor relations material
Bioventus Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary16 Mar, 2026
Market leadership and growth prospects
Holds leadership positions across pain treatments, surgical solutions, and restorative therapies, with a $6.4B addressable market and $568M in 2025 revenue.
Focuses on differentiated energy and orthobiologic solutions for musculoskeletal conditions.
Portfolio includes HA viscosupplements, PRP, PNS, ultrasonics, and bone graft substitutes.
Strategic actions and financial performance
Advanced portfolio with new growth drivers and divested non-core assets.
Achieved 7.5% organic revenue growth and 20.5% adjusted EBITDA margin in 2025, with future targets above 10% growth and ~25% margin.
Delivered over $100M in operating cash flow and expanded EBITDA margins by ~700 bps.
Growth portfolio and investment priorities
Core products (HA, BGS, fracture care) drive majority of sales and strong margins.
Emerging platforms (PNS, PRP) and expansion areas (ultrasonics, international) targeted for accelerated growth.
Investments prioritized for PNS sales force, international expansion, and R&D for PNS and ultrasonics.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bioventus
- Q4 2025 saw double-digit organic growth, margin expansion, and record cash flow.BVS
Q4 20255 Mar 2026 - Q2 revenue up 10.3%, guidance raised, with $31.9M impairment and litigation settlement.BVSQ2 20242 Feb 2026
- Accelerated growth, margin expansion, and debt reduction position for substantial value creation.BVSCanaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026
- Q3 revenue up 15%, guidance raised, divestiture and litigation drive key financial changes.BVSQ3 202416 Jan 2026
- Transformation and strategic investments drive strong growth, high margins, and global expansion.BVS44th Annual J.P. Morgan Healthcare Conference14 Jan 2026
- Strong 2024 growth and margin gains set up for doubled free cash flow and lower leverage in 2025.BVS43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
- Q4 revenue up 14%, margin expansion, and 2025 guidance targets 6–8% organic growth.BVSQ4 202426 Dec 2025
- Shelf registration enables $200M in offerings and large shareholder sales, with dilution risk.BVSRegistration Filing16 Dec 2025
- Strong growth, margin expansion, and innovation drive future investment flexibility and value.BVSPiper Sandler 37th Annual Healthcare Conference3 Dec 2025
Next Bioventus earnings date
Q1 20265 May, 2026
Bioventus
Next Bioventus earnings date
Q1 20265 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage